ClinicalTrials.govpublic full text
Survival Prolongation by Rationale Innovative Genomics
non-small cell lung cancer metastatic, non-small cell lung cancer stage iiib, nsclc, tri-therapy, avelumab, axitinib, palbociclib, dual matched normal and tumor biopsies, sims algorithm, sequencing, gene expression, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 905060
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.